What is the ICD-10 code for superficial esophageal carcinoma with hyperparathyroidism?

The ICD-10 code for superficial esophageal carcinoma is C15.5, and for secondary hyperparathyroidism due to malignancy, it is E21.1.

How do you document hyperparathyroidism secondary to esophageal cancer?

Document the linkage by stating 'secondary to PTHrP secretion from esophageal carcinoma' and include lab results showing elevated calcium and PTHrP levels.

ICD-10 Coding for Superficial Esophageal Carcinoma with Hyperparathyroidism(C15.5, C15.4, C15.9)

Save

Learn about the ICD-10 coding for superficial esophageal carcinoma with secondary hyperparathyroidism, including documentation requirements and coding pitfalls.

Also known as:

Esophageal Cancer with Secondary HyperparathyroidismEsophageal SCC with Hypercalcemia

Related ICD-10 Code Ranges

Complete code families applicable to Superficial Esophageal Carcinoma with Hyperparathyroidism

C00-D49Primary Range

Neoplasms

→

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

Code	Description	When to Use	Key Documentation
C15.5	Malignant neoplasm of lower third of esophagus	Use when esophageal carcinoma is confirmed in the lower third of the esophagus.	Histological confirmation of esophageal carcinoma Imaging studies showing tumor location
E21.1	Secondary hyperparathyroidism, not elsewhere classified	Use when hyperparathyroidism is secondary to esophageal carcinoma.	Elevated serum calcium and PTHrP levels Documentation linking hyperparathyroidism to esophageal carcinoma

Primary ICD-10-CM Codes

Malignant neoplasm of lower third of esophagus

C15.5Billable

Differential Codes

Alternative codes to consider when ruling out similar conditions

Malignant neoplasm of esophagus, unspecifiedC15.9

Secondary hyperparathyroidism of renal originN25.81

Documentation & Coding Risks

Avoid these common issues when documenting Superficial Esophageal Carcinoma with Hyperparathyroidism.

Omitting the linkage between hyperparathyroidism and carcinoma

Impact

Clinical: Misrepresentation of the patient's condition., Regulatory: Potential for audit and compliance issues., Financial: Denied claims due to incomplete documentation.

Mitigation

Ensure documentation explicitly links the conditions., Regular training on documentation standards.

Incorrect sequencing of codes

Impact

Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation

Always sequence the malignancy code (C15.x) before the hyperparathyroidism code (E21.1).

Code Sequencing

Impact

Incorrect sequencing of primary and secondary codes.

Mitigation

Educate staff on proper sequencing rules and conduct regular audits.

Frequently Asked Questions

Documentation requirements, coding pitfalls and FAQs for conditions coded with C15.5.

Primary Code

C15.5

Malignant neoplasm of lower third of esophagus

Quick Navigation

ICD-10 codes6

Coding risks3

FAQs2

ICD-10 Coding for Superficial Esophageal Carcinoma with Hyperparathyroidism(C15.5, C15.4, C15.9)

Documentation & Coding Risks

Frequently Asked Questions

What is the ICD-10 code for superficial esophageal carcinoma with hyperparathyroidism?

How do you document hyperparathyroidism secondary to esophageal cancer?

Related condition guides